Identification of HIF-1α/VEGFA signaling pathway and transcription factors in Kashin-Beck disease by integrated bioinformatics analysis.
Kashin-Beck disease
T-2 toxin
chondrocyte
hypoxia-inducible factor/1α
vascular endothelial growth factor A
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
08
06
2020
accepted:
16
07
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
ppublish
Résumé
Kashin-Beck disease (KBD) is a chronic and endemic osteoarthropathy. The pathogenesis of KBD has yet to be fully elucidated, although previous studies have shown that its etiology may be associated with low selenium abundance and high exposure to mycotoxins, such as T-2 toxin. In the present study, the Comparative Toxicogenomics Database was used to identify key genes associated with KBD, T-2 toxin and selenium. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were used to identify the biological processes and pathways that key genes may be associated with. By searching the Search Tool for the Retrieval of Interacting Genes database and the Molecular Complex Detection plug-in with Cytoscape, it was possible to construct a KBD-associated protein-protein interaction (PPI) network, and screen the core modules and genes. Western blot analysis was subsequently used to verify the expression levels of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor A (VEGFA), two components that are associated with the HIF-1 signaling pathway in KBD disease. Via this approach, a total of 301 key genes were identified that were associated with KBD, T-2 toxin and selenium. The results of the GO and KEGG enrichment analyses demonstrated that these key genes were mainly involved in the process of apoptosis. Previous studies have demonstrated that excessive apoptosis of chondrocytes plays a crucial role in the pathophysiology of KBD, and that HIF-1α has an important role in chondrocyte apoptosis; therefore, the present study was focused on the expression level of HIF-1α in KBD. By analyzing the PPI network constructed from the key genes, a total of 10 core genes were obtained that may be associated with KBD. The results of western blotting experiments revealed that, after treating chondrocytes with different concentrations of T-2 toxin, the expression levels of HIF-1α and VEGFA were markedly downregulated. The iRegulon plug-in for Cytoscape was used to predict the transcription factors that may regulate HIF-1α and VEGFA in the HIF-1 signaling pathway. Using this approach, 10 core genes and 15 transcription factors were obtained. These results may help to clarify the pathogenesis of KBD, thereby providing further avenues for the therapeutic treatment of KBD.
Identifiants
pubmed: 34504569
doi: 10.3892/etm.2021.10549
pii: ETM-0-0-10549
pmc: PMC8383754
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1115Informations de copyright
Copyright: © Xiao et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Hepatology. 2020 Jun;71(6):2105-2117
pubmed: 31529728
Bone. 2018 Dec;117:15-22
pubmed: 30153510
J Cell Mol Med. 2019 May;23(5):3711-3723
pubmed: 30920152
Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954
pubmed: 30247620
Sci Rep. 2017 Dec 14;7(1):17553
pubmed: 29242531
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Aug;31(8):1314-7
pubmed: 21868312
Biol Trace Elem Res. 2016 May;171(1):34-40
pubmed: 26349761
Joint Bone Spine. 2015 May;82(3):144-7
pubmed: 25553838
Scand J Rheumatol. 2013;42(1):71-9
pubmed: 23157206
Front Pharmacol. 2018 May 01;9:263
pubmed: 29765317
Arthritis Res Ther. 2005;7(4):R904-14
pubmed: 15987493
Exp Cell Res. 2017 Dec 1;361(1):141-148
pubmed: 29042209
Biol Trace Elem Res. 2019 Aug;190(2):295-302
pubmed: 30406490
Hum Exp Toxicol. 2021 May;40(5):869-881
pubmed: 33233966
Nat Rev Rheumatol. 2012 Mar 27;8(6):358-66
pubmed: 22450551
Toxicon. 2020 Oct 30;186:12-18
pubmed: 32698025
Osteoarthritis Cartilage. 2012 Jul;20(7):605-13
pubmed: 22370124
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Arthritis Rheum. 2010 Mar;62(3):771-80
pubmed: 20131229
J Rheumatol. 2006 Mar;33(3):615-9
pubmed: 16511931
PLoS Comput Biol. 2014 Jul 24;10(7):e1003731
pubmed: 25058159
Int Orthop. 2001;25(3):175-9
pubmed: 11482536
Environ Toxicol Pharmacol. 2002 Jul;11(3-4):309-20
pubmed: 21782614
J Bone Miner Metab. 2006;24(4):319-28
pubmed: 16816927
Autophagy. 2015;11(6):967-9
pubmed: 25997392
Osteoarthritis Cartilage. 2013 Nov;21(11):1781-9
pubmed: 23948978
Int J Cancer. 2016 Mar 1;138(5):1058-66
pubmed: 25784597
Sci Rep. 2017 May 22;7(1):2231
pubmed: 28533525
Exp Cell Res. 2019 Jun 15;379(2):140-149
pubmed: 30951708
Sci Rep. 2017 Apr 3;7(1):540
pubmed: 28373711
Osteoarthritis Cartilage. 2010 Jun;18(6):817-24
pubmed: 20178852
Bone. 2019 Mar;120:239-245
pubmed: 29653292
Osteoarthritis Cartilage. 2015 Feb;23(2):210-6
pubmed: 25433273
Osteoarthritis Cartilage. 2015 Sep;23(9):1575-85
pubmed: 25917637
Mol Cell. 2010 Oct 22;40(2):294-309
pubmed: 20965423
Biol Trace Elem Res. 2019 Aug;190(2):303-308
pubmed: 30474788
Mol Immunol. 2017 Nov;91:195-201
pubmed: 28963928
Osteoarthritis Cartilage. 2009 Jan;17(1):83-90
pubmed: 18579416
Biomed Pharmacother. 2018 Jun;102:1209-1220
pubmed: 29710540
Toxicol In Vitro. 2012 Oct;26(7):1106-13
pubmed: 22800716
Food Chem Toxicol. 2020 Jan;135:110968
pubmed: 31738984
Int Orthop. 2001;25(3):147-50
pubmed: 11482528
PLoS One. 2011;6(7):e22983
pubmed: 21829570
Pain. 2020 Dec;161(12):2750-2762
pubmed: 32569086
Oncology. 2005;69 Suppl 3:4-10
pubmed: 16301830
Arch Toxicol. 2020 Nov;94(11):3645-3669
pubmed: 32910237
Arthritis Res Ther. 2018 Mar 7;20(1):41
pubmed: 29514696
J Cell Biochem. 2015 May;116(5):696-703
pubmed: 25546605
Semin Arthritis Rheum. 2020 Apr;50(2):366-372
pubmed: 31548049